^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | Non Small Cell Lung Cancer |
| Drug: | albumin-bound paclitaxel (Bcl2 inhibitor, Tubulin inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Published date:
03/16/2022
Excerpt:
Non-Small Cell Lung Cancer: Useful in Certain Circumstances…Albumin-bound paclitaxel
Non-Small Cell Lung Cancer….Subsequent Systemic Therapy Option….Other Recommended: Albumin-bound paclitaxel added….PS 0-2: Albumin-bound paclitaxel added as a category 2B.
